Details for New Drug Application (NDA): 062508
✉ Email this page to a colleague
NDA 062508 describes ERYMAX, which is a drug marketed by Merz Pharms and is included in one NDA. Additional details are available on the ERYMAX profile page.
The generic ingredient in ERYMAX is erythromycin. There are one hundred and three drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
The generic ingredient in ERYMAX is erythromycin. There are one hundred and three drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
Summary for 062508
| Tradename: | ERYMAX |
| Applicant: | Merz Pharms |
| Ingredient: | erythromycin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062508
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;TOPICAL | Strength | 2% | ||||
| Approval Date: | Jul 11, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
